Home link: Post hospital care to reduce HIV mortality in South Africa

NIH RePORTER · NIH · R34 · $78,389 · view on reporter.nih.gov ↗

Abstract

PROJECT SUMMARY The availability of antiretroviral therapy (ART) has markedly reduced HIV-related mortality and morbidity in Africa. Yet HIV remains the leading cause of death among adult men and women in South Africa due failure to initiate ART or remain in care. South Africa has approximately 7.1 million people with HIV; 8-13% experience hospitalization at one of the 85,000 public hospital beds in South Africa. Approximately 26% of this hospitalized group dies within 6 months of hospital discharge representing as much as 50% of the 110,000 excess HIV-related deaths in South Africa may be occurring during the post-hospital period. Preliminary work completed by the study team among 122 participants discharged from a single hospital has identified a failure to remain connected with care following hospital discharge as a factor associated with mortality and readmission. This team has also explored barriers to care, including challenges with traveling to care during the period of convalescence, long queue times, and frequent return visits all adding the burden of treatment. This project seeks to test whether overcoming these challenges by bringing care and psychosocial counseling to the convalescing individual can overcome barriers to sustained engagement in care following discharge and reduce post- hospital mortality. We hypothesize that by overcoming structural and psychosocial barriers to care continuity post-hospital mortality will be reduced. The current proposal will allow for the development and piloting of this household clinical visits, or Home Link, strategy to improve post-hospital care and to increase knowledge regarding care engagement during this vulnerable period and to prepare for a randomized clinical trial of the Home Link intervention powered for an efficacy outcome of mortality 6 months after hospital discharge.

Key facts

NIH application ID
10167787
Project number
5R34MH118998-03
Recipient
JOHNS HOPKINS UNIVERSITY
Principal Investigator
CHRISTOPHER J HOFFMANN
Activity code
R34
Funding institute
NIH
Fiscal year
2021
Award amount
$78,389
Award type
5
Project period
2019-08-09 → 2023-05-31